文献速递耳科与耳神经小儿耳鼻咽喉

儿童多基因风险评分与听力损失表型

Polygenic Risk Scores and Hearing Loss Phenotypes in Children.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2024-11-07

这项横断面研究合并澳大利亚两个人群队列(CheckPoint 1488名11-12岁儿童与VicCHILD 527名0-13岁儿童),分析基于英国生物银行成人自报听力困难的全基因组关联研究结果计算的多基因风险评分与儿童听力损失表型的关联。结果显示,多基因风险评分每增加1个标准差,与单侧轻度、中度、重度或更差听力损失的比值比分别为1.3、5.1、5.3,与双侧及所有类型听力损失的风险升高相关。

要点

  • 多基因风险评分每增加1个标准差,与单侧轻度听力损失相关(OR 1.3;95%CI 1.0-1.6)。
  • 多基因风险评分与单侧中度(OR 5.1;95%CI 3.2-8.1)及重度或更差(OR 5.3;95%CI 3.9-7.3)听力损失相关。
  • 多基因风险评分与双侧听力损失(每标准差OR 3.9-6.6)及所有听力损失类型(每标准差OR 8.5-10.6)相关。

核心结论

  • 在横断面研究中,最初为成人听力困难开发的多基因风险评分与广泛的儿童听力损失表型相关。
  • 该评分部分解释了尽管共享遗传和环境因素(如早产)但听力表型仍存在变异的现象。
  • 作者认为,采用客观定义听力表型的大规模研究对于完善多基因风险评分和预测高风险儿童至关重要。

研究设计与样本

  • 横断面研究,使用澳大利亚两个同期人群队列:Child Health CheckPoint(嵌入澳大利亚儿童纵向研究的全国人群横断面研究)和维多利亚儿童听力纵向数据库(VicCHILD,面向澳大利亚维多利亚州所有先天性听力损失儿童的州级人群纵向数据库)。
  • 纳入1488名CheckPoint研究儿童(49.8%男孩,11-12岁)和527名VicCHILD研究儿童(55.2%男孩,0-13岁),均有听力和基因型数据。
  • 分析时间为2023年3月至8月。
  • 暴露:基因型数据来自唾液或血液DNA,使用全球单核苷酸变异阵列生成;多基因风险评分基于已发表的英国生物银行全基因组关联研究结果计算,该结果针对40至69岁个体自报听力困难。
  • 主要结局与测量:听力结局按侧别(双侧、单侧)、严重程度(轻度、中度、重度或更差)和类型(感音神经性、传导性、混合性、听神经病、闭锁)分类;分析包括多基因风险评分与听力结局的多项逻辑回归。

主要发现

  • 与正常听力相比,多基因风险评分每增加1个标准差,与单侧轻度听力损失(OR 1.3;95%CI 1.0-1.6)、单侧中度听力损失(OR 5.1;95%CI 3.2-8.1)和单侧重度或更差听力损失(OR 5.3;95%CI 3.9-7.3)的比值比升高相关。
  • 多基因风险评分与双侧轻度、中度和重度或更差听力损失的比值比升高相关(每标准差OR 3.9-6.6)。
  • 多基因风险评分与所有听力损失类型的比值比升高相关(每标准差OR 8.5-10.6)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Monogenic causes of childhood hearing loss are well established, as are polygenic risk contributions to age-related hearing loss. However, an untested possibility is that polygenic risk scores (PRS) also contribute to childhood hearing loss of all severities, alongside environmental and/or monogenic causes. OBJECTIVE: To examine the association between a PRS for adult hearing loss and childhood hearing loss phenotypes. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used a unique population-based dataset spanning normal hearing to profound loss, combining 2 contemporaneous population cohorts in Australia. This included the Child Health CheckPoint, a national population-based cross-sectional study nested within the Longitudinal Study of Australian Children, and the Victorian Childhood Hearing Longitudinal Databank (VicCHILD), a statewide population-based longitudinal data bank open to every child with congenital hearing loss in Victoria, Australia. The analysis took place from March to August 2023. EXPOSURES: Genotype data were generated from saliva- or blood-derived DNA using global single-nucleotide variations arrays. Based on genotype data, PRS was computed using published UK Biobank genome-wide association study results for self-reported hearing difficulty in individuals aged 40 to 69 years. MAIN OUTCOMES AND MEASURES: Hearing outcomes were classified by laterality (bilateral, unilateral), severity (mild, moderate, severe or worse) and types (sensorineural, conductive, mixed, auditory neuropathy, atresia). Analyses included multinominal logistic regressions of PRS with hearing outcomes. RESULTS: Overall, 1488 CheckPoint study children (49.8% boys, aged 11-12 years) and 527 VicCHILD study children (55.2% boys, aged 0-13 years) with hearing and genotype data were included. A 1-SD increment in PRS was associated with higher odds of mild (odds ratio [OR], 1.3; 95% CI, 1.0-1.6), moderate (OR, 5.1; 95% CI, 3.2-8.1), and severe or worse (OR, 5.3; 95% CI, 3.9-7.3) unilateral hearing loss compared with normal hearing. Similarly, the PRS was associated with increased odds of mild, moderate, and severe or worse bilateral hearing loss (per-SD ORs, 3.9-6.6) and all hearing loss types (per-SD ORs, 8.5-10.6). CONCLUSIONS AND RELEVANCE: In this cross-sectional study, a PRS initially developed for adult hearing difficulty was associated with wide-ranging childhood hearing loss phenotypes, partly explaining hearing phenotype variations despite shared genetic and environmental factors (eg, preterm birth). Large-scale studies with objectively defined hearing phenotypes are crucial for refining PRS and predicting high-risk children.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Wang J, He F, Shepherd DA, et al. Polygenic Risk Scores and Hearing Loss Phenotypes in Children. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 39509092. doi:10.1001/jamaoto.2024.3659

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。